BioTime, Inc. Announces 14 New Patents For iPSC Applications (WSJ)

 

(Alameda, CA) BioTime announced the issuance of 14 new patents to add to the largest known patent estate under one corporate umbrella in the field of pluripotent stem cell technology.

PUBMED ARTICLES CLINICAL TRIALS